For nearly 150 years, we've been turning science into medicine, taking on the toughest diseases to help improve lives in ways that have changed the course of human health. Today, we continue this pursuit in disease areas like Alzheimer's disease, cancer, diabetes and obesity to help as many people as possible live healthier lives.
Erich Brechtelsbauer, PharmD, MS serves as an Oncology Health Outcomes Liaison at Eli Lilly. He provides medical, health economic, and health outcomes research support to cancer population-based decision makers across the Veteran's Affairs enterprise.